There are compelling situations that argue for the benefits that connected inhalers may provide patients, the primary benefit being better patient outcomes. Potential benefits for and possible concerns of healthcare providers, pharmacies, pharmaceutical manufacturers and payers are discussed.
Patients who use inhalers and other stakeholders are eager for better solutions to improve outcomes. The most obvious and important benefit of connected inhalers is providing assistance for patients, which may increase their adherence. Connected inhalers may also help improve communication and treatment while reducing costs. In addition, potential benefits for and possible concerns of healthcare providers, pharmacies, pharmaceutical manufacturers and payers are considered.